Development and characterization of a walnut protein hydrolysate-Fe-vitamin C complex: Enhancing iron bioavailability through phytase-assisted modification
- Food Chem. 2025 Oct 3;496(Pt 1):146646. doi: 10.1016/j.foodchem.2025.146646.
- 1. State Key Laboratory of Efficient Production of Forest Resources, Beijing Key Laboratory of Forest Processing and Safety, School of Biological Sciences and Technology, Beijing Forestry University, Beijing 100083, China; Hebei Province Key Laboratory of Sustainable Utilization and Development of Forest Food Resources, China.
- 2. State Key Laboratory of Efficient Production of Forest Resources, Beijing Key Laboratory of Forest Processing and Safety, School of Biological Sciences and Technology, Beijing Forestry University, Beijing 100083, China; Hebei Province Key Laboratory of Sustainable Utilization and Development of Forest Food Resources, China. Electronic address: [email protected].
- 3. State Key Laboratory of Efficient Production of Forest Resources, Beijing Key Laboratory of Forest Processing and Safety, School of Biological Sciences and Technology, Beijing Forestry University, Beijing 100083, China; Hebei Province Key Laboratory of Sustainable Utilization and Development of Forest Food Resources, China. Electronic address: [email protected].
In this study, walnut protein was treated with phytase and Alcalase to produce walnut protein hydrolysate (WPHP). Phytase hydrolysis reduced phytic acid‑iron interactions, exposing peptide binding sites and enabling strong Fe2+ chelation rate of 80.78 ± 0.58 %. Vitamin C was subsequently added to form WPHP-Fe-vitamin C complex, which was stabilized through Fe-carboxyl and Fe‑carbonyl coordination and hydrogen bonding, accompanied by structural reorganization. The complex exhibited a porous microstructure, particle size of 345.76 nm, solubility of 90.22 % at pH 7.0, and stabilized under varying pH, ionic, and thermal conditions. Compared with WPHP-Fe, the complex showed higher iron retention. Caco-2 assays revealed that vitamin C mitigated the inhibitory effect of phytic acid and significantly enhanced Fe2+ uptake via the DMT1 pathway, reaching 9.47 ± 0.13 μg/well at 120 min. These results highlight the complementary roles of phytase and vitamin C and support the complex as a peptide-based iron supplement.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
target: FerroportinResearch Areas: Metabolic Disease